CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conti, G.
Right arrow Articles by Proietti, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conti, G.
Right arrow Articles by Proietti, R.
Canadian Journal of Anesthesia 51:494-499 (2004)
© Canadian Anesthesiologists' Society, 2004
Neuroanesthesia and Intensive Care

Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration: a pilot study

[La sédation avec du sufentanil chez des patients qui reçoivent une assistance ventilatoire inspiratoire n’a pas d’effet sur la respiration : une étude pilote]

Giorgio Conti, MD, Andrea Arcangeli, MD, Massimo Antonelli, MD, Franco Cavaliere, MD, Roberta Costa, MD, Francesca Simeoni, MD and Rodolfo Proietti, MD

From the Department of Anesthesia and Intensive Care, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Rome, Italy.

Address correspondence to: Dr. Giorgio Conti, Department of Anesthesia and Intensive Care, Università Cattolica del S. Cuore, Policlinico A. Gemelli, Largo A. Gemelli 8,00168 Rome, Italy. Phone: + 39 06 30154386; Fax: + 39 06 3013450; E-mail: g.conti{at}rm.unicatt.it

Purpose: To evaluate the effects of sedation with sufentanil on respiratory drive, respiratory pattern, and gas exchange of critically ill patients during pressure support ventilation.

Methods: In this prospective observational cohort study, we observed 12 adult patients receiving partial ventilatory support for acute respiratory failure. Each subject received a continuous infusion of sufentanil at 0.2 to 0.3 µg•kg–1•hr–1 to obtain a modified Ramsay sedation score between 2 and 3. In basal conditions and at variable distance from the beginning of the sufentanil infusion (10’, 30’, 60’, 120’, 24 hr) we evaluated gas exchange, hemodynamic variables, respiratory rate (RR), tidal volume (TV), respiratory pattern, respiratory drive (P0.1) and inspiratory impedance of the respiratory system [P0.1/TV/inspiratory time (Ti)].

Results: The continuous iv administration of 0.2 to 0.3 µg•kg–1•hr–1 of sufentanil resulted in the desired level of sedation. No significant heart rate, heart rhythm and blood pressure changes were observed. Sufentanil infusion did not affect TV, minute volume, Ti/inspiratory duty cycle, RR, P0.1, P0.1/TV/Ti and gas exchange did not change significantly over the study period.

Conclusion: A continuous infusion of sufentanil induces "awake" sedation with no detectable effects on respiratory variables in critically ill patients during partial ventilatory support.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.